Late development of hepatocellular carcinoma after viral clearance in patients with chronic hepatitis C: A need for continual surveillance
- 11 June 2018
- journal article
- research article
- Published by Wiley in Journal of Digestive Diseases
- Vol. 19 (7) , 411-420
Abstract
OBJECTIVE: Eradication of chronic hepatitis C (CHC) infection decreases the incidence of hepatocellular carcinoma (HCC), but a risk remains. We aimed to investigate HCC development‐associated factors in CHC patients with sustained virological response (SVR) after antiviral therapies.METHODS: We compared CHC patients achieving SVR from 1996–2016 who did and did not develop HCC. Their median follow‐up period was 8.01 years.RESULTS: Compared with 164 non‐HCC SVR patients, 22 who developed HCC were older at SVR (P = 0.032), had a higher incidence of diabetes (P = 0.013) and higher pre‐antiviral treatment alpha‐fetoprotein (AFP) levels (P = 0.016), more had fibrosis stage 3 and cirrhosis (P = 0.0009) and hepatitis B core antibody (anti‐HBc) positivity (P = 0.006). Eight and seven of 22 patients, respectively, developed HCC at 4–10 years and 10 years after SVR. The longest duration from SVR to HCC was 18.7 years. Independent factors associated with HCC development were anti‐HBc positivity (hazard ratio [HR] 5.57, P = 0.012), age at SVR (HR 1.08, P = 0.014), higher pre‐antiviral treatment AFP levels (HR 1.01, P = 0.01) and Hispanic ethnicity (HR 12.9, P = 0.002). HCC risk was significantly less in genotype 2 patients (HR 0.2, P = 0.02) or in those with higher pre‐antiviral treatment albumin levels (HR 0.33, P = 0.04).CONCLUSIONS: The risk for HCC exists in a subset of CHC patients after SVR and may occur up to 18 years after viral clearance. Indefinite HCC surveillance is necessary in SVR patients with other risk factors.Keywords
This publication has 49 references indexed in Scilit:
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: Systematic review and meta‐analysisInternational Journal of Cancer, 2010
- Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinomaJournal of Viral Hepatitis, 2010
- Development of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface AntigenClinical Gastroenterology and Hepatology, 2009
- Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography†Hepatology, 2009
- Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapyJournal of Gastroenterology and Hepatology, 2005
- Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferonJournal of Gastroenterology, 2005
- Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complicationsGut, 2004